Streetbeat News

Revenues

ADN

Advent Technologies has signed a €1.8 million frame contract with Volta Energy to supply methanol-powered fuel cell units. Deliveries are scheduled to start in January 2024 and continue throughout the year to meet the customer's timeline.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:17 pm

CRWD

CrowdStrike (NASDAQ:CRWD) and Optiv have surpassed $1 billion in sales of the CrowdStrike Falcon platform through their partnership. This milestone highlights the success of their collaboration in modernizing cybersecurity across various industries. CrowdStrike's Falcon platform, combined with Optiv's partner program, has driven growth and reduced risk for customers. CrowdStrike also achieved over $1 billion in AWS Marketplace sales and was recognized as a growth leader in a Canalys report, with a 39.1% growth rate in channel sales.

Portfolio Pulse from Happy Mohamed

December 18, 2023 | 2:12 pm

FTTUSD

FTX Trading is proposing a plan to return money to creditors as part of its bankruptcy case. The proposal involves liquidating most of the firm's cryptocurrencies and valuing the assets in cash based on their value at the time of the bankruptcy filing on November 11, 2022. Creditors will vote on the proposal before it goes to U.S. Bankruptcy Judge John Dorsey for final approval. Major creditor and customer groups have tentatively approved the plan, but it does not clarify if FTX will resume operations or how much creditors will receive. FTX has been allowed to sell assets, including its subsidiary LedgerX for $50 million.

Portfolio Pulse from Khyathi Dalal

December 18, 2023 | 2:08 pm

ESOA

Energy Services of America reported an increase in FY23 earnings per share (EPS) to $0.44 from $0.24 in the previous year. Revenue also rose to $304.104 million from $197.590 million year-over-year.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 2:03 pm

SGBX

SGD

Safe & Green Holdings Corp. (SGBX) has signed a Master Purchase Agreement with its real estate development subsidiary, Safe and Green Development Corporation (SGD), post-spinout. The agreement, valued over $140M, tasks SG Echo, a subsidiary of SGBX, with manufacturing modular units for SG DevCo's real estate projects. The projects are expected to generate over $800M in gross revenue. The deal is anticipated to maximize factory utilization and improve operating margins for SGBX due to economies of scale.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:34 pm

VCIG

VCI Global Limited (NASDAQ:VCIG) has acquired a 51% stake in a special purpose vehicle (SPV) for CAD$12.1M, which includes assets from Nextech3D.AI Corporation's AI 3D modeling platform. This platform has seen a significant demand with over 50,000 3D models delivered, contributing to a 97% revenue growth for Nextech3D.AI in the first nine months of 2023. The global 3D modeling market is projected to grow at a CAGR of up to 20% until 2030, indicating a substantial market opportunity for VCI Global.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:32 pm

FRSX

Foresight Autonomous Holdings Ltd. (FRSX) has entered into an exclusive agreement with Elbit Systems, which is anticipated to generate $4 million in revenue over a five-year period. This strategic partnership is expected to enhance Foresight's market position and financial performance by providing a steady income stream.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:16 pm

LEN

Lennar Corporation has expanded its New York market presence by acquiring 1,273 homesites in the Tuxedo Reserve master-planned community from Related Companies. The community, located in Tuxedo, New York, will feature a variety of housing options including townhomes and single-family homes, with amenities such as hiking trails and a clubhouse. The grand opening is scheduled for the second half of 2024, aiming to attract homebuyers seeking the Hudson Valley lifestyle. Financial terms of the acquisition were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:12 pm

RARE

Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) announced the European Commission's approval of Evkeeza for children aged 5+ with homozygous familial hypercholesterolemia (HoFH). The approval is based on a Phase 3 study showing a 48% reduction in LDL-C levels at week 24. Evkeeza is now available in the U.S., Canada, Italy, Germany, and through early access in Austria and France. The treatment is the first ANGPTL3 inhibitor for children as young as 5 to control high LDL-C levels due to HoFH.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:08 pm

BHC

Bausch Health Companies, through its Canadian subsidiary, has announced that DUOBRII is now available to patients covered by Quebec's public drug plan. This expands the availability of DUOBRII, which is already included in most public drug plans across Canada and covered by most private drug insurance plans.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 1:06 pm